Grupo Zendal | Prensa

El Grupo Zendal

Zendal Portugal

Biofarmacéuticos

14 · 12 · 2023International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.

20 · 11 · 2023Innovative project against bacterial resistance and a protective vaccine for bees, winners of the Zendal Awards

25 · 10 · 2023Zendal launches its human health vaccine manufacturing plant in the Portuguese town of Paredes de Coura

02 · 10 · 2023The jury for the Zendal Awards, which will be presented at a gala in Vigo on November 16, has been officially established.

13 · 07 · 2023Germany issues award to IAVI to support development of the MTBVAC tuberculosis vaccine candidate

03 · 07 · 2023Zendal and Reig Jofre appointed by the EU to ensure vaccine production capacity in Europe in case of future health emergencies

29 · 06 · 2023 First annual project meeting

16 · 06 · 2023Zendal holds in Porriño a meeting of its innovation centres

01 · 06 · 2023Zendal Group announces the 4th edition of its awards aimed at recognising human and animal health projects

19 · 05 · 2023Spanish biotech Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC

05 · 05 · 2023FEUGA holds the Governing Board in Zendal

18 · 04 · 2023Zendal holds an integration day with the recently acquired Laboratorios Maymó

1
2
3